The multiplicative nature of the interaction of cardiovascular risk factors (RF) warrants more aggressive management in multiple (high) risk individuals. In order to test the hypothesis that physicians do not recognize or treat multiple RF patients more aggressively than those with single RF, we measured univariate RF control rates in hypertension, hypercholesterolemia and diabetes, then calculated predicted bivariate and trivariate control rates from univariate values. The predicted rates were subsequently compared to observed values. The study population consisted of 1172 hypertensive diabetics admitted to a general hospital from June 30, 1998 -July 31, 1999. ICD9 codes were used to define diabetes and antihypertensive drug use to define hypertension. Patients with heart failure were excluded. Available hospitalized systolic blood pressures on treatment (HSBP), glycated hemoglobin (HbA 1c ) and LDL cholesterol were related to values recommended by the American Diabetes Association and JNC VI guidelines (SBPՅ130 mmHg, HbA 1c Յ7% and LDLՅ100 mg/dL). Results: Population meansϮSD were as follows: Ageϭ66Ϯ12 years, HSBPϭ139Ϯ24mmHg, HbA 1c ϭ7.9Ϯ1.6%, LDLϭ102Ϯ45 mg/dL. The univariate control rates for HSBP, LDL and HbA 1c were 42%, 46% and 32% respectively. The predicted and observed control rates for patients with 2 or 3 risk factors controlled to target were:
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In conclusion, our data demonstrate that adequate control of multiple risk factors occurs in less than 20% of patients with 2 risk factors and less than 8% of patients with 3 risk factors. Physicians do not recognize or treat the multiple risk syndrome as aggressively as the condition warrants. Normal pregnancy is associated to increased levels of leptin which appears to be exacerbated in preeclampsia. We conducted this study to verify the profile of leptin in adolescents during normal gestation (NG) and pre-eclampsia (PE). We studied 19 adolescents (12-18 yrs of age), 5 who developed PE, and 15 with NG, during the hole gestation. Serum leptin levels were evaluated by radioimmunoassay, and blood pressure (BP) using DINAMAP 1846. Patients who presented BP Ͼ140 /90 mmHg and proteinuria Ͼ300 mg/24 h, without previous hypertension were considered with PE. To adjust for Body Mass Index (BMI), we used the ratio of leptin to BMI, to compare the evolution in both groups, Leptin levels and BMI increased during NG and PE reaching the highest values after 30 weeks of gestation. During NG, leptin correlated significantly with BMI at 21-30 weeks (rϭ0.71; pϽ0.0004) and after 30 weeks of gestation (rϭ0.94; pϽ0.0001). These correlations were lost both at 20 -30 weeks (rϭ0.8; pϭ0.1) and Ͼ30 weeks of gestation (rϭ0.7, pϭ0.2) in PE. Although leptin levels were not different between groups, the leptin to BMI ratio was significantly lower in NG when compared to PE: 21-30 weeks: 0.44Ϯ0.02 and 0.56Ϯ0.06 ng/dl (pϭ0.04), respectively; after 30 weeks: 0.41Ϯ0.04 and 0.70Ϯ0.15 (pϭ0.03), respectively. In adolescents, leptin to BMI ratio appears to indicate a higher risk of PE. 
